midland nose surgery limited
midland nose surgery limited Company Information
Company Number
10964360
Website
www.midlandnose.surgeryRegistered Address
church court stourbridge road, halesowen, west midlands, B63 3TT
Industry
Other human health activities
Telephone
01902793269
Next Accounts Due
June 2025
Group Structure
View All
Directors
James Barraclough6 Years
Shareholders
james philip barraclough 67%
alice lloyd 33%
midland nose surgery limited Estimated Valuation
The estimated valuation range for midland nose surgery limited, derived from financial data as of September 2023 and the most recent industry multiples, is between £0 to £57.3k
midland nose surgery limited Estimated Valuation
The estimated valuation range for midland nose surgery limited, derived from financial data as of September 2023 and the most recent industry multiples, is between £0 to £57.3k
midland nose surgery limited Estimated Valuation
The estimated valuation range for midland nose surgery limited, derived from financial data as of September 2023 and the most recent industry multiples, is between £0 to £57.3k
Get a detailed valuation report, edit figures and unlock valuation multiples.
Midland Nose Surgery Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Midland Nose Surgery Limited Overview
Midland Nose Surgery Limited is a live company located in west midlands, B63 3TT with a Companies House number of 10964360. It operates in the other human health activities sector, SIC Code 86900. Founded in September 2017, it's largest shareholder is james philip barraclough with a 67% stake. Midland Nose Surgery Limited is a young, micro sized company, Pomanda has estimated its turnover at £136.5k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Midland Nose Surgery Limited Health Check
Pomanda's financial health check has awarded Midland Nose Surgery Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
7 Weak
Size
annual sales of £136.5k, make it smaller than the average company (£701.4k)
- Midland Nose Surgery Limited
£701.4k - Industry AVG
Growth
3 year (CAGR) sales growth of -10%, show it is growing at a slower rate (5.6%)
- Midland Nose Surgery Limited
5.6% - Industry AVG
Production
with a gross margin of 21%, this company has a higher cost of product (36%)
- Midland Nose Surgery Limited
36% - Industry AVG
Profitability
an operating margin of -71.8% make it less profitable than the average company (5.5%)
- Midland Nose Surgery Limited
5.5% - Industry AVG
Employees
with 2 employees, this is below the industry average (18)
2 - Midland Nose Surgery Limited
18 - Industry AVG
Pay Structure
on an average salary of £25.2k, the company has an equivalent pay structure (£25.2k)
- Midland Nose Surgery Limited
£25.2k - Industry AVG
Efficiency
resulting in sales per employee of £68.2k, this is more efficient (£46.2k)
- Midland Nose Surgery Limited
£46.2k - Industry AVG
Debtor Days
it gets paid by customers after 101 days, this is later than average (22 days)
- Midland Nose Surgery Limited
22 days - Industry AVG
Creditor Days
its suppliers are paid after 49 days, this is slower than average (17 days)
- Midland Nose Surgery Limited
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Midland Nose Surgery Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Midland Nose Surgery Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 38.9%, this is a higher level of debt than the average (23.2%)
38.9% - Midland Nose Surgery Limited
23.2% - Industry AVG
midland nose surgery limited Credit Report and Business Information
Midland Nose Surgery Limited Competitor Analysis
Perform a competitor analysis for midland nose surgery limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
midland nose surgery limited Ownership
MIDLAND NOSE SURGERY LIMITED group structure
Midland Nose Surgery Limited has no subsidiary companies.
Ultimate parent company
MIDLAND NOSE SURGERY LIMITED
10964360
midland nose surgery limited directors
Midland Nose Surgery Limited currently has 1 director, Mr James Barraclough serving since Sep 2017.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr James Barraclough | England | 46 years | Sep 2017 | - | Director |
MIDLAND NOSE SURGERY LIMITED financials
Midland Nose Surgery Limited's latest turnover from September 2023 is estimated at £136.5 thousand and the company has net assets of £23.1 thousand. According to their latest financial statements, Midland Nose Surgery Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | 2 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 608 | 1,277 | 1,946 | 2,615 | 240 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 608 | 1,277 | 1,946 | 2,615 | 240 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 37,853 | 135,104 | 111,824 | 59,750 | 19,109 | 16,639 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 37,853 | 135,104 | 111,824 | 59,750 | 19,109 | 16,639 |
| total assets | 37,853 | 135,712 | 113,101 | 61,696 | 21,724 | 16,879 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 14,720 | 14,562 | 14,798 | 12,977 | 11,769 | 16,682 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 14,720 | 14,562 | 14,798 | 12,977 | 11,769 | 16,682 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 14,720 | 14,562 | 14,798 | 12,977 | 11,769 | 16,682 |
| net assets | 23,133 | 121,150 | 98,303 | 48,719 | 9,955 | 197 |
| total shareholders funds | 23,133 | 121,150 | 98,303 | 48,719 | 9,955 | 197 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | ||||||
| Amortisation | ||||||
| Tax | ||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -97,251 | 23,280 | 52,074 | 40,641 | 2,470 | 16,639 |
| Creditors | 158 | -236 | 1,821 | 1,208 | -4,913 | 16,682 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 |
P&L
September 2023turnover
136.5k
-59%
operating profit
-98k
0%
gross margin
21%
-2.76%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
23.1k
-0.81%
total assets
37.9k
-0.72%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
midland nose surgery limited company details
company number
10964360
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
September 2017
age
7
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
church court stourbridge road, halesowen, west midlands, B63 3TT
last accounts submitted
September 2022
midland nose surgery limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to midland nose surgery limited.
midland nose surgery limited Companies House Filings - See Documents
| date | description | view/download |
|---|
